VF
KRSA

Virtu Financial’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Virtu Financial’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-347
Closed -$32K – 1622
2022
Q4 		$32K Buy
+347
New +$4.11K ﹤0.01% 1164
2021
Q4 		– Sell
-395
Closed -$170K – 1800
2021
Q3 		$170K Sell
395
-179
-31% -$11.7K 0.02% 965
2021
Q2 		$313K Sell
574
-59
-9% -$3.69K 0.03% 699
2021
Q1 		$247K Buy
+633
New +$47.5K 0.02% 933
2020
Q4 		– Sell
-74
Closed -$63K – 1497
2020
Q3 		$63K Buy
+74
New +$8.46K 0.01% 785

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's KRSA Position: Q1 2023 in Review

Virtu Financial sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2023, closing a stake of 347 shares — an estimated $32K sold.

Virtu Financial first reported a position in KRSA in Q3 2020 and held it in 5 quarters. The position peaked at $313K in Q2 2021. 30 funds tracked by Wall St. Rank hold KRSA as of Q1 2023.

  • Virtu Financial reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Virtu Financial sold 347 Korsana Biosciences, Inc. Common Stock shares in Q1 2023, an estimated $32K.
  • Virtu Financial first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Virtu Financial's Korsana Biosciences, Inc. Common Stock position peaked at $313K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.